Filter
1056
Filtered Results: 1056
Text search:
Anti-Tuberculosis
medicines
Featured
Recommendations
138
New Publications
379
Language
Document type
No document type
701
Guidelines
128
Studies & Reports
114
Manuals
52
Strategic & Response Plan
24
Fact sheets
12
Training Material
11
Situation Updates
10
Infographics
3
Resource Platforms
1
Countries / Regions
India
66
Kenya
38
Uganda
33
Western and Central Europe
31
Ethiopia
27
Global
25
Ghana
24
Zambia
24
Tanzania
23
South Africa
23
Liberia
21
Nigeria
21
Eastern Europe
21
Nepal
19
Myanmar / Burma
18
Malawi
17
Namibia
17
Philippines
13
Rwanda
13
Bangladesh
13
Sierra Leone
12
Ukraine
11
Asia
11
Africa
11
Zimbabwe
10
Cambodia
10
Latin America and the Carribbean
10
Lesotho
9
Russia
9
Botswana
7
South–East Asia Region
7
Venezuela
7
Pakistan
5
Mozambique
5
Eswatini/ Swaziland
5
Syria
4
Colombia
4
East and Southern Africa
4
Senegal
3
Cameroon
3
Afghanistan
3
Thailand
3
Indonesia
3
Vietnam
3
Haiti
2
Somalia
2
Jordan
2
Lebanon
2
Bolivia
2
Libya
2
Yemen
2
Eastern Europe and Central Asia
2
Poland
2
Albania
2
Tajikistan
2
Moldova
2
Turkmenistan
2
Burkina Faso
1
Congo, Democratic Republic of
1
Mali
1
Saudi Arabia
1
Iraq
1
Germany
1
Egypt
1
Gambia
1
Papua New Guinea
1
Sudan
1
Benin
1
Argentina
1
Peru
1
Brazil
1
North Macedonia
1
Hungary
1
Sri Lanka
1
Chile
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Palestine
1
Djibouti
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Qatar
1
Iran
1
Georgia
1
North America
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
482
Clinical Guidelines
123
Public Health
55
Women & Child Health
34
Pharmacy & Technologies
15
Key Resources
14
Capacity Building
10
Toolboxes
TB
230
HIV
107
AMR
61
Pharmacy
60
COVID-19
25
Mental Health
23
NCDs
19
Caregiver
18
Global Health Education
15
NTDs
14
Refugee
12
Conflict
11
Polio
9
Rapid Response
6
Planetary Health
6
Disability
5
Ebola
5
Health Financing Toolbox
5
Specific Hazards
2
Natural Hazards
1
Health Financing
1
R4D conducted a thorough desk review and qualitative fiscal space analysis, 19 interviews about financing for the three diseases and the extent of alignment between public financial management systems and health policy objectives, and a validation workshop with government officials.
Tanzania’...
Tanzania’...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income Countries
recommended
2nd edition.
The practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential ... (EML) and the Model List of Essential Medicine for Children (EMLc).
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and formulation on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog...
Management of Diabetes Mellitus-Tuberculosis
recommended
1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guideli...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for innovative approaches and strategies to mainta...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment ...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare...
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health m.... The list is intended to support decisions regarding the production, quality assurance, national procurement and reimbursement schemes of these medicines.
